Vaxxinity

About:

Vaxxinity is a biotechnology company that enables the innovation of synthetic peptide vaccines to prevent or treat infectious diseases.

Website: https://vaxxinity.com/

Twitter/X: vaxxinity

Top Investors: Coalition for Epidemic Preparedness Innovations, White Buffalo Capital

Description:

Vaxxinity, Inc. is a U.S.-based, clinical stage biotechnology company, that aims to democratize health by bringing the efficiency of vaccines to chronic diseases. Vaxxinity has a proprietary technology platform that has enabled the innovation of synthetic peptide vaccines designed to treat and prevent chronic diseases, including Alzheimer's, Parkinson's, migraine, and hypercholesterolemia, as well as infectious diseases, including COVID-19. Vaxxinity has designed its pipeline to achieve a historic global impact on human health.

Total Funding Amount:

$9.25M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Dallas, Texas, United States

Founded Date:

2019-01-01

Founders:

Lou Reese, Mei Mei Hu, Peter Diamandis

Number of Employees:

11-50

Last Funding Date:

2022-04-07

IPO Status:

Public

Industries:

© 2025 bioDAO.ai